(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BIOWEST THE SERUM SPECIALIST

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: Estados Unidos

Snapshot rápido

BIOWEST THE SERUM SPECIALIST

ST13

US500000087050094

Classe

1, 5

Pedido

87050094

Registro

5646125

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

42

Atualização mais recente

09/04/2025

Tipo de marca

Mista

Classes Nice

1, 5

Data de depósito

25/05/2016

Data de registro

08/01/2019

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

08/04/2025

Última transação

09/04/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

702

Cadastro oficial

Principal Register

Primeiro uso

01/07/2000

Primeiro uso no comércio

01/07/2000

Código do desenho

5

Tipo de titular

16

Localização do titular

Bradenton, FL

Examinador

PERKINS, ELLEN

Localização atual

Historical data usage

Descrição da marca

The mark consists of the lowercase stylized wording "biowest" centered on top of the wording "The Serum Specialist".

Titulares e representantes

Titulares

Biowest, L.L.C.
Biowest, L.L.C.

Representantes

Cheryl L. Burbach HOVEY WILLIAMS LLP

Classificação técnica

Classes Nice

Classe 1Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Cell culture media for scientific and research use; Biological tissue culturesother than for medical or veterinary purposes; all the foregoing for use in production of active ingredients of pharmaceuticals

Classe 5

Vaccines; antitoxic sera; culture media for medical usenamely augmentationdifferentiationpreservationcultivation of bonetissuecellsmicroorganism cells for medical purposes; culture media for veterinary usenamely augmentationdifferentiationpreservationcultivation of bonetissuecellsmicroorganism cells for veterinary purposes; diagnostic media for bacteriological cultures; biological preparations for medical purposesuse in cell cultures; blood culture media for medical and veterinary usefor augmentationdifferentiationpreservationcultivation of bonetissuecellsmicroorganism cellsfor use in production of active ingredients of pharmaceuticals; protein arrays for medical use in binding and detecting antibodies; antitoxic sera for medical purposesuse in vaccinescell and tissue cultures and in growth media supplements; antibiotics; reagents for medical use; chemical reagents for medical or veterinary purposes; saline wash for medical purposes; saline solution for medical purposes; bacteriological culture mediums; cultures of microorganisms for medical or veterinary use; veterinary and pharmaceutical preparations for the treatment of infectious diseases; mixed biological preparations for the prevention and treatment of infectious diseases

Publicações

Histórico de despachos e eventos da marca no USPTO.

42 publicações encontradas

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/04/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/04/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/04/2025

E815

TEAS SECTION 8 & 15 RECEIVED

23/12/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/01/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

23/10/2018

PUBO

PUBLISHED FOR OPPOSITION

23/10/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/10/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

17/09/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/09/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/08/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/08/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

16/08/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

21/07/2018

GNRT

NON-FINAL ACTION E-MAILED

21/07/2018

CNRT

NON-FINAL ACTION WRITTEN

21/07/2018

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

13/07/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/07/2018

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

20/06/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

20/06/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/06/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

15/05/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/05/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

15/05/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

15/11/2017

GNRT

NON-FINAL ACTION E-MAILED

15/11/2017

CNRT

NON-FINAL ACTION WRITTEN

15/11/2017

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

24/10/2017

ALIE

ASSIGNED TO LIE

19/10/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/04/2017

GNSL

LETTER OF SUSPENSION E-MAILED

06/04/2017

CNSL

SUSPENSION LETTER WRITTEN

06/04/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/03/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/03/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

16/03/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

17/09/2016

GNRT

NON-FINAL ACTION E-MAILED

17/09/2016

CNRT

NON-FINAL ACTION WRITTEN

17/09/2016

DOCK

ASSIGNED TO EXAMINER

09/09/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/06/2016

NWAP

NEW APPLICATION ENTERED

28/05/2016

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BIOWEST THE SERUM SPECIALIST ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.